BC Platforms

BCP provides a unique data and technology platform to enable life sciences and healthcare companies to access, manage and analyze clinical and omics data. BCP’s Data Access Platform provides access and related technology to valuable data (RWD, Clinical, Genomics, and Omics) for the Life Science Industry. The Company’s Data Partner Network currently covers more than 22m life-years of highly curated patient data from around the world and is steadily growing. These data are made accessible to Pharma companies through a data-as-a-service (DaaS) model. BCP is able to provide Life Science companies with transformational capabilities to access longitudinal clinical and genome data across the globe to enhance different use cases within the R&D continuum, speeding up the process from early discovery to clinical and post-market access processes. BCP’s technology platform provides technology to Healthcare Providers and Life Science companies to produce, manage and analyze complex genomics as a clinical decision-support solution, analyze the data (genomics- omics and clinical) and make it available for any research ensuring compatibility with all relevant technical standards and in compliance with local privacy law in different jurisdictions.

BC Platforms headquartered in Switzerland, Europe, operates in the Software, Life Science, Analytics, Health Care, Pharmaceutical, Precision Medicine sector. The company focuses on Software and has secured $4.4B in funding across 96 round(s). With a team of 101-250 employees, BC Platforms is actively contributing to advancements in Software. Their latest funding round, Series B - BC Platforms, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.